ID: ALA3219496

Max Phase: Preclinical

Molecular Formula: C8H16N2O3

Molecular Weight: 188.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCNCCC(=O)NCCC(=O)O

Standard InChI:  InChI=1S/C8H16N2O3/c1-2-9-5-3-7(11)10-6-4-8(12)13/h9H,2-6H2,1H3,(H,10,11)(H,12,13)

Standard InChI Key:  LGBOWZXTAPZTCG-UHFFFAOYSA-N

Associated Targets(Human)

Glutamate [NMDA] receptor 933 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 188.23Molecular Weight (Monoisotopic): 188.1161AlogP: -0.42#Rotatable Bonds: 7
Polar Surface Area: 78.43Molecular Species: ZWITTERIONHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.08CX Basic pKa: 9.71CX LogP: -3.46CX LogD: -3.46
Aromatic Rings: 0Heavy Atoms: 13QED Weighted: 0.47Np Likeness Score: -0.72

References

1. Reymond J, van Deursen R, Blum LC, Ruddigkeit L.  (2010)  Chemical space as a source for new drugs,  (1): [10.1039/C0MD00020E]

Source